Therefore, it is possible that excess activation of hepatic GK over a long period could cause hypertriglyceridemia, while the ability of TMG-123 to activate GK without increasing Vmax (Fig 1) could be ideal for clinical use. This evidence concerns the gene GK and hypertriglyceridemia.